These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8448541)

  • 21. Contemporaneous appearance, 18 years after allogeneic bone marrow transplantation, of myelodysplastic syndrome in the patient and the donor.
    Orciuolo E; Azzarà A; Bandini G; Galimberti S; Bonifazi F; Fazzi R; Petrini M
    Bone Marrow Transplant; 2004 Apr; 33(8):859-61. PubMed ID: 14743194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Donor selection for allogenic bone marrow transplantation from 1991 to 1995. (The Prague Center for Bone Marrow Transplantation)].
    Korínková P; Matĕjková E; Vítek A
    Cas Lek Cesk; 1996 Jun; 135(12):389-92. PubMed ID: 8706078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individuals.
    Kiss TL; Chang H; Daly A; Messner HA; Jamal N; Spaner D; Rubin S; Lipton JH
    Bone Marrow Transplant; 2004 Apr; 33(8):855-8. PubMed ID: 14990983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent infection with human T lymphotropic virus type 1 after allogeneic bone marrow transplantation from a seronegative donor.
    Kanda Y; Taketazu F; Chiba S; Yazaki Y; Hirai H
    Bone Marrow Transplant; 1999 Aug; 24(3):349. PubMed ID: 10455380
    [No Abstract]   [Full Text] [Related]  

  • 25. Allogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Transplant Registry.
    Horowitz MM; Rowlings PA; Passweg JR
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S5-6. PubMed ID: 8769690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.
    Lee SH; Lee MH; Lee JH; Min YH; Lee KH; Cheong JW; Lee J; Park KW; Kang JH; Kim K; Kim WS; Jung CW; Choi SJ; Lee JH; Park K
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):122-8. PubMed ID: 15682073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bone marrow transplant: current perspectives].
    Abecasis MM
    Acta Med Port; 1989 Nov; Suppl 2():S16-20. PubMed ID: 2694784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic donor bone marrow cells recovery and infusion after allogeneic face transplantation from the same donor.
    Hequet O; Morelon E; Bourgeot JP; Dubois V; Devauchelle B; Dubernard JM; Michallet M
    Bone Marrow Transplant; 2008 Jun; 41(12):1059-61. PubMed ID: 18317458
    [No Abstract]   [Full Text] [Related]  

  • 29. Allogeneic bone marrow transplantation from a donor with severe active rheumatoid arthritis not resulting in adoptive transfer of disease to recipient.
    Snowden JA; Atkinson K; Kearney P; Brooks P; Biggs JC
    Bone Marrow Transplant; 1997 Jul; 20(1):71-3. PubMed ID: 9232261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Idiopathic hyperammonemia following allogeneic bone marrow transplantation for refractory lymphoma].
    Watanabe R; Okamoto S; Asahi A; Mori T; Takayama N; Ikeda Y
    Rinsho Ketsueki; 2000 Dec; 41(12):1285-8. PubMed ID: 11201156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical problems in BMT from alternative donors.
    Bernasconi C
    Bone Marrow Transplant; 1993; 11 Suppl 1():59-61. PubMed ID: 8448550
    [No Abstract]   [Full Text] [Related]  

  • 32. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gamma delta T lymphocyte regeneration after T lymphocyte-depleted bone marrow transplantation from mismatched family members or matched unrelated donors.
    Cela ME; Holladay MS; Rooney CM; Richardson S; Alexander B; Krance RA; Brenner MK; Heslop HE
    Bone Marrow Transplant; 1996 Feb; 17(2):243-7. PubMed ID: 8640174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor leukocyte transfusions and discontinuation of immunosuppressants to achieve an initial remission after allogeneic bone marrow transplantation in a patient with primary refractory acute leukemia.
    Azuno Y; Kaneko T; Nishimura M; Okuya S; Nakai K; Nomiyama J; Mori K; Okafuji K; Okubo M; Matsutani A; Kamei S; Zaitsu Y; Takeuchi Y; Oka Y; Kaku K
    Bone Marrow Transplant; 1996 Jul; 18(1):257-9. PubMed ID: 8832032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toward the success of bone marrow transplantation from unrelated donors.
    Yoshida Y
    Int J Hematol; 1994 Apr; 59(3):v-vi. PubMed ID: 8011985
    [No Abstract]   [Full Text] [Related]  

  • 37. Buccal swabs but not mouthwash samples can be used to obtain pretransplant DNA fingerprints from recipients of allogeneic bone marrow transplants.
    Thiede C; Prange-Krex G; Freiberg-Richter J; Bornhäuser M; Ehninger G
    Bone Marrow Transplant; 2000 Mar; 25(5):575-7. PubMed ID: 10713640
    [No Abstract]   [Full Text] [Related]  

  • 38. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B; Li DP; Xu KL; Pan XY
    Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic bone marrow transplantation of chronic myeloid leukemia from an HLA-matched unrelated donor with the beta-thalassemic trait.
    Sue YC; Liu TC; Chang CS; Huang SM; Chen TP; Lin SF
    Int J Hematol; 1999 Apr; 69(3):200-2. PubMed ID: 10222660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation.
    Glasser L; Meloni-Ehrig A; Greaves W; Demel KC; Butera J
    Transfusion; 2009 Mar; 49(3):555-62. PubMed ID: 19040490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.